arXiv:2606. 17113v1 Announce Type: new Abstract: Distinguishing causal adverse drug events (ADEs) from spurious correlations remains a central challenge in pharmacovigilance.
By Csaba Kiss, Roland Molontay, Gabriele Pergola
arXiv:2607. 18086v1 Announce Type: new Abstract: Background: LLM judges increasingly score whether clinical language models give overconfident answers under incomplete evidence, yet whether a measured "safety gain" reflects real behavior change or the judge's calibration is unresolved.
By Koyar Afrasyab
arXiv:2610.41368v1 Announce Type: new
Abstract: Overly restrictive eligibility criteria contribute to widespread enrollment failure in clinical trials, yet published recommendations for how specific...
By Russell Ro, Reza Abbasi-Asl
arXiv:2606. 03198v1 Announce Type: cross Abstract: Clinical AI evaluation increasingly delegates scoring to large language models (LLMs) acting as AI raters, yet their scoring behavior across evaluation conditions has not been quantitatively characterized.
By Sangwon Baek, Kyu Yeon Hur, Kyunga Kim
The paper introduces a retrieval‑augmented multi‑agent framework that automatically generates instance‑specific evaluation rubrics for medical language models. By retrieving authoritative medical evidence, decomposing it into atomic facts, and combining these with user interaction constraints, the system produces fine‑grained criteria that outperform GPT‑4o on HealthBench and LLMEval‑Med. The generated rubrics also guide response refinement, improving medical LLM output quality by 9.2%.
By Yinzhu Chen, Abdine Maiga, Hossein A. Rahmani, Emine Yilmaz
arXiv:2606. 26205v1 Announce Type: new Abstract: Patients increasingly seek medication information online, yet safety knowledge for psychiatric drugs is split between regulatory adverse-event records, which are authoritative but abstract, and patient narratives, which are experience-near but unvalidated.
By Huizi Yu, Jian Liu, Wenkong Wang, Lingyao Li, Jiayan Zhou, Zhaoqian Xue, Xiang Li, Xinxin Lin, Zhiying Liang, Zhuoru Wu, Siyuan Ma, Xin Ma, Lizhou Fan
arXiv:2606. 11830v1 Announce Type: new Abstract: Background.
By Qianyu Yao, Fei Sun, Bocheng Huang, Wei Chen, Jiarui Jiang, Shu Quan, Yifei Chen, Wenjie Xu, Bo li, Liping Su, Ruoqiong Wu, Huhai Hong, Huimei Wang
The paper introduces a joint fact‑verification score that evaluates both answers and the evidence submitted with them. On the FEVEROUS dataset, replacing the DCUF evidence with UnifEE evidence improves the strict score by about 9.6 percentage points, while answer accuracy rises only 1.96 points. The study also shows that increasing context length for large language models yields modest evidence‑gain improvements, and that detailed answer‑evidence analyses uncover patterns missed by aggregate metrics.
By Han Chen, Yingrui Li
arXiv:2609.21859v1 Announce Type: new
Abstract: Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely o...
By Jiacheng Lin, Zifeng Wang, Zheng Chen, Erick Scott, Ziwei Yang, Fanyang Yu, Sheng Zhong, Jimeng Sun
arXiv:2604. 07709v4 Announce Type: replace-cross Abstract: A heavily safety-trained model will hand a physician the full, patient-followable benzodiazepine taper and refuse it to the patient who needs it, over identical clinical facts; the knowledge is present either way.
By David Gringras
arXiv:2408. 13378v5 Announce Type: replace Abstract: Workflows in drug-target interaction (DTI) assessment require integrating heterogeneous data from predictive models, curated resources, and observations from experimental literature.
By Yoshitaka Inoue, Tianci Song, Xinling Wang, Rui Kuang, Tianfan Fu, Augustin Luna
arXiv:2607. 18828v1 Announce Type: new Abstract: Readiness stress-testing of medical AI has focused on closed-ended and multimodal benchmarks.
By Koyar Afrasyab